Edit Content

Contact Us


    Human Verification

    cropped-gtc_logo_grey_circle_2022

    Utilize the first AI software for diagnosing DLBCL

    Utilize the first AI software for diagnosing DLBCL

    GTC is the first and only diagnostic lab to deploy true artificial intelligence (AI) software for classifications of lymphoma.

    Do not accept partial results, send your lymphoma to GTC for comprehensive classification using RNA/DNA and artificial intelligence. Get results in 7 days for DNA and 10 days for RNA

    A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

    GTC was recently published in Blood Advances with an article titled (click URL below to read it):
    A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

    Key points:
    – A DLBCL cell-of-origin classifier integrating both genetic and gene expression signatures show robust predictive values in DLBCL cohorts.
    – Targeted NGS and AI enable potential applications of fast and reliable DLBCL classification assays in clinical practice.

    GTC’s hematology profiles are covered by Medicare. To learn more contact us info@Genomictestingcooperative.com

    YOU MAY ALSO ENJOY THESE ARTICLES:

    Case Study: VEXAS Syndrome

    Background VEXAS syndrome is a disease with inflammatory and hematologic (blood) manifestations. The syndrome is caused by mutations in the UBA1 gene affecting the Met41 residue of the protein and resulting in

    Read More »

    Subscribe to our Newsletter

    Get all the critical news and events sent straight to your inbox

    Share this post with your friends

    Leave a Reply